Change Control Software: Manage Regulatory Change from Request to Implementation

Every change type. Structured impact. Gated on training.

Change Control Software for Regulated Industries

Regulatory change control is not the same thing as project management change management. When a project manager talks about change management, they mean managing the human side of organizational transformation: communication plans, stakeholder engagement, and resistance mitigation. When a quality professional in a regulated industry talks about change control, they mean formally documenting a proposed change to a controlled process, product, or system; evaluating its impact on regulatory compliance, product quality, and validated state; obtaining the required approvals; and confirming that every downstream consequence — revised documents, revalidated processes, retrained staff, updated regulatory submissions — is addressed before the change goes live.

A buyer who arrives at this page looking for project management tools will find the distinction made clearly and will be redirected appropriately. A quality professional in pharmaceutical manufacturing, medical device production, life sciences, or regulated manufacturing who needs change control software for a GMP, ISO 13485, or ISO 9001 quality system is in the right place.

This page covers the regulatory requirements that govern change control in regulated industries, the five distinct change types that regulated quality systems manage, how eLeaP structures impact assessment to route each change to the right reviewers, and how change approval automatically generates the training assignments that gate implementation.

Regulatory Change Control vs. Generic Change Management: Why the Distinction Matters

Generic change management software — project management platforms, workflow tools, document collaboration systems — can track that a change was proposed and approved. What those tools cannot do is evaluate whether the change affects validated processes, identify which downstream regulatory submissions require updating, determine which employees need retraining before the change is implemented, or prevent the change from going live before those consequences are addressed.

Regulatory change control in life sciences and regulated manufacturing is governed by explicit requirements that a generic workflow tool cannot satisfy. ICH Q10 Section 3.2.3 requires that a Change Management System be established as one of the four elements of the Pharmaceutical Quality System, with formal processes for evaluating the impact of changes to processes, equipment, facilities, analytical methods, specifications, and quality systems — including impact assessment, approval, and post-implementation review. Under QMSR (21 CFR Part 820, effective February 2, 2026), process validation requirements are governed by ISO 13485 Clause 7.5.6, which requires that changes to validated processes be evaluated and revalidated where necessary to ensure the process continues to produce product meeting requirements. ISO 13485 Clause 7.3.9 requires that changes during design and development be identified, reviewed, verified, validated, and approved before implementation.

The consequence of a change that bypasses or inadequately completes the regulatory change control process is not an administrative deficiency — it is a potential product quality failure. A process change implemented without revalidation may operate outside the validated design space without the quality system detecting it. A procedure change implemented before affected staff are retrained means production continues under the old procedure until the training gap is closed — or until an inspector finds it. eLeaP’s change control software is built around preventing these consequences structurally rather than documenting them after the fact.

The most common change control observation in FDA inspections is not the absence of a change control procedure. It is a change control procedure that exists on paper but is bypassed under production pressure — or one that closes without confirming that training was complete before implementation.

Five Change Types in Regulated Industries — Each Requiring a Different Workflow

A change control system that treats all changes as the same record type with the same workflow is a compliance documentation tool, not an operational quality management system. The regulatory impact of a document revision to a reference SOP is categorically different from the impact of a change to a validated aseptic filling process. eLeaP configures distinct change control workflows for each of the following change types, with impact assessment fields, approval routing, and implementation gating appropriate to the regulatory obligations of each.

Document Changes

Changes to controlled documents — SOPs, work instructions, specifications, test methods, batch record templates — are the most frequent change type in any regulated quality system. Document changes require author and approver sign-off with 21 CFR Part 11-compliant electronic signatures, automatic supersession of the prior version on the effective date, distribution to affected roles, and retraining assignment for every employee whose job function requires training on the revised document. In eLeaP, a document change control record links to the document it revises, routes through the configured approval workflow for the document type, and triggers training assignments on the effective date without any manual action by the document owner or training administrator.

Process Changes to Validated Manufacturing Methods

Changes to validated manufacturing processes carry the highest regulatory consequence of any change type in pharmaceutical and medical device manufacturing. A change to a validated process — a change to critical process parameters, to equipment used in the validated process, to the validated cleaning method, or to the validated sterilization cycle — requires an impact assessment against the validated state, a determination of whether the change falls within the established design space or requires revalidation, and a post-implementation review confirming the process performs as expected after the change. Under ISO 13485 Clause 7.5.6 and equivalent GMP requirements, revalidation is required where changes affect the ability of the validated process to produce product meeting requirements.

In eLeaP, process change control records include a validated state impact assessment field, route to process validation and regulatory affairs reviewers when validation impact is identified, and cannot close until post-implementation review is documented.

Equipment Changes Requiring Requalification

Equipment changes — replacement of a component with a different manufacturer’s part, modification of a control system, relocation of equipment within a facility, installation of new equipment in a qualified process area — require assessment against the equipment’s qualification status. A change that falls outside the qualified operating range requires requalification before the equipment returns to GMP use. In eLeaP, equipment change control records link to the equipment qualification record, identify the IQ/OQ/PQ protocols that must be reviewed against the proposed change, and route to the equipment owner and validation team for qualification impact assessment. Requalification activities required by the change are tracked as action items within the change control record, and the change cannot be closed until all required requalification is completed and documented.

Software Changes Requiring Validation

Changes to computerized systems used in GMP applications — laboratory information management systems, manufacturing execution systems, enterprise resource planning systems, and the QMS platform itself — require change control under the predicate rules governing those systems: 21 CFR Part 211.68 and 211.100 for pharmaceutical GMP systems, ISO 13485 Clause 7.5.6 and QMSR for medical device systems. 21 CFR Part 11 governs how the electronic records and signatures documenting those changes must be maintained — it defines the requirements for the audit trail, access controls, and electronic signature meaning captured in the change control record, but the change control mandate itself derives from the underlying predicate regulations. For manufacturers with European operations, EU Annex 11 governs computerized system validation change control requirements. A software change that affects the functionality of a validated system requires an impact assessment against the system’s validated state, a determination of whether the change requires revalidation or can be addressed through a change assessment with regression testing, and an update to the system’s validation documentation to reflect the change. In eLeaP, software change control records include a validated system impact assessment, route to the system owner and validation responsible for impact evaluation, and generate an update task for the affected validation documentation packages.

Organizational Changes Affecting Responsibilities

Organizational changes — role redefinitions, reporting line changes, responsibility transfers between functions, site reorganizations — affect the quality system in ways that are less visible than process or equipment changes but equally consequential for regulatory compliance. When a quality assurance responsibility transfers from one function to another, the procedures governing that responsibility must be updated, the approval matrices in the quality system must be revised, and the training records for the incoming function must reflect training on the responsibilities being assumed. In eLeaP, organizational change control records route to the quality system manager and the affected function heads, identify the documents and approval matrices requiring update, and generate training assignments for the incoming responsibility holders before the organizational change is effective.

Impact Assessment: The Step That Determines How a Change Must Be Managed

A change control record that reaches approval without a thorough impact assessment has documented that a change was approved — not that the change was evaluated. Impact assessment is what converts a change control process from a documentation exercise into a genuine quality risk management activity. It asks and answers every question that determines how the change must be managed and what downstream actions the change requires before implementation.

In eLeaP, the impact assessment is a structured stage in the change control workflow with discrete questions for each impact domain. It is not a free-text field — it is a guided evaluation that requires the change owner and reviewers to address each domain explicitly. Skipping an impact domain is not possible without documenting that the domain was evaluated and found not applicable.

Who Is Affected: Routing to the Right Reviewers

The impact assessment begins by identifying which functions are affected by the change. A process change affecting production methods routes to production, quality, and validation. A change affecting a customer-facing specification routes to regulatory affairs and commercial quality. A change to a procedure used by multiple sites routes to each site’s quality function. In eLeaP, the impact assessment drives the approval routing configuration: functions identified as affected receive review and approval tasks in the change control workflow. Functions not identified as affected are not added to the approval sequence, keeping routing proportionate to actual impact.

Which Documents Need Revision

A change to a manufacturing process typically requires revision of the batch record, the relevant SOPs, the process validation protocol and report, and the master batch formula. A change to equipment may require revision of the equipment qualification protocols, the related cleaning procedure, and any SOPs that reference the equipment. The impact assessment identifies each document requiring revision, and the change control record generates a document revision task for each. Document revision tasks link back to the change control record so each revision is traceable to the change that necessitated it — providing the audit trail an investigator expects when reviewing why a document was revised.

Which Processes Need Revalidation

The validation impact assessment is the most consequential component for process and equipment changes. The assessor evaluates the proposed change against the validated design space, the critical process parameters, the critical quality attributes, and the validation acceptance criteria. If the change falls within the established design space and validated operating ranges, a change assessment with supporting data may be sufficient. If the change falls outside the validated design space or affects a critical process parameter, revalidation is required before implementation.

In eLeaP, the validation impact determination is a required field in the impact assessment. A ‘revalidation required’ determination automatically generates a revalidation action item in the change control record and prevents implementation sign-off until the revalidation is completed and documented.

Which Regulatory Submissions Need Updating

For pharmaceutical manufacturers, some process and product changes require prior FDA approval before implementation — Prior Approval Supplements governed by 21 CFR Part 314.70 for approved NDA applications. Others require notification within 30 days of implementation — Changes Being Effected supplements under the same regulation. For medical device manufacturers, changes affecting the device’s design, labeling, or intended use may require a new 510(k) submission or a PMA supplement. The regulatory submission impact assessment identifies whether the change falls into a prior approval, notification, or annual report category, generates a regulatory affairs review task, and tracks the submission status within the change control record. A change that requires prior approval cannot advance to implementation until the regulatory submission is approved.

Training Before Implementation: How Change Control Gates on Training Completion

The most common training gap in regulated manufacturing is not a missing training program. It is the interval between a change going live and the affected employees being trained on it. The change is approved. The revised procedure is effective. Production continues. The training assignment is created manually, sometimes after the change is implemented. Employees work under the new procedure before they have been trained on it. At the next inspection, the investigator finds training records referencing the prior procedure version for employees who have been working under the revised version for weeks.

eLeaP closes this gap structurally. When a change control record is approved — all reviewers have signed, all pre-implementation actions are complete except training — the system creates training assignments for every employee in the roles identified as affected during the impact assessment. The training assignments carry the change control record number, the specific revised document version, and the required completion date. The change control record enters an ‘awaiting training completion’ status. Implementation sign-off — the step that confirms the change is live and the prior procedure is superseded — is not available until the required training completions are confirmed in the system.

The implementation gate is not a soft reminder. It is a system constraint. A change control owner cannot mark the change as implemented while required training assignments show an open status, regardless of pressure from production or project timelines.

This gives the quality professional a defensible position when asked why implementation was delayed: the training was not complete, and the system correctly prevented implementation until it was. The training completion record and the change control record are linked — the audit trail shows what was required, who completed it, and when, before the implementation sign-off was permitted.

For changes that affect multiple sites, the training completion requirement applies at each affected site before implementation at that site. A change can be implemented at Site A when Site A’s training is complete, even if Site B’s training is still in progress. The per-site implementation tracking in eLeaP reflects the operational reality of multi-site organizations while maintaining the training gate at each location.

Post-Implementation Review: Confirming the Change Achieved Its Intended Outcome

Change control does not end at implementation. ICH Q10 Section 3.2.3 requires post-implementation review as part of the Change Management System element of the Pharmaceutical Quality System — confirming the change achieved its intended outcome without adversely affecting product quality or regulatory compliance. The post-implementation review is the change control equivalent of CAPA effectiveness verification — it confirms the change worked as intended and that no unintended consequences appeared during the initial implementation period.

In eLeaP, the post-implementation review is a scheduled stage in the change control workflow with a defined review date set at the time of change approval. The review date is typically set 30 to 90 days after implementation, depending on the change type and production volume at the affected process. The post-implementation review requires the change owner and the quality reviewer to assess process performance data from the post-implementation period, confirm that the intended outcome was achieved, and document any observations or concerns. If the review identifies an unintended consequence — a process trending outside its normal operating range, an increase in nonconformances at the affected operation — the review can initiate a CAPA directly from within the change control record.

Evaluating Change Control Software: Five Questions That Reveal Regulatory Depth

Change control software ranges from generic workflow tools marketed to regulated industries to purpose-built quality management platforms with change-type-specific workflow logic. The depth of implementation varies widely between platforms that all describe regulated change management capabilities. The five questions below distinguish a change tracking system from a regulatory change control engine. Require live demonstration for each.

eLeaP’s answers to all five questions are yes, demonstrable in a scoped walkthrough configured for your change types and regulatory framework. The demo covers a validated process change from initiation through impact assessment, validation impact determination, training gate, implementation sign-off, and post-implementation review against GMP or ISO 13485 requirements as applicable.

Frequently Asked Questions

What is change control software?

Change control software is a quality system application that manages the formal process for proposing, evaluating, approving, implementing, and reviewing changes to controlled processes, products, documents, equipment, and systems in a regulated organization. In regulated industries, change control software must satisfy the requirements of the applicable quality management framework: ICH Q10 Section 3.2.3 for pharmaceutical manufacturers, ISO 13485 Clauses 7.3.9 and 7.5.6 for medical device manufacturers, and ISO 9001 Clauses 6.3 and 8.5.6 for ISO-certified quality systems. The distinction between change control software and a change tracking tool is whether the platform enforces the impact assessment, approval routing, and pre-implementation requirements or merely records that the change was approved.

What is the difference between change control and change management?

In regulated industries, change control is a specific quality system process — formally documenting, evaluating, approving, and verifying implementation of a change to a controlled process, product, document, or system, with documented impact assessment and regulatory compliance evaluation at each step. Change management, in the project management sense, refers to managing the organizational and human dimensions of transitions: communication, stakeholder engagement, and adoption. The two processes overlap in that major regulatory changes require both — but they are managed by different functions (quality versus project management) under different regulatory frameworks.

What are the regulatory requirements for change control in pharmaceutical manufacturing?

For pharmaceutical manufacturers, the primary regulatory framework for change control is ICH Q10 Section 3.2.3, which establishes the Change Management System as a required element of the Pharmaceutical Quality System — covering changes to processes, equipment, facilities, analytical methods, specifications, and quality systems, with formal impact assessment, appropriate approvals, and post-implementation review. Changes to approved drug applications are governed by 21 CFR Part 314.70, which defines three categories: Prior Approval Supplements (requiring FDA approval before implementation), Changes Being Effected supplements (requiring notification within 30 days), and annual reportable changes. For computerized systems used in GMP environments, the mandate for change control derives from predicate rules — 21 CFR Part 211.68 for pharmaceutical computerized laboratory systems and 21 CFR Part 211.100 for written procedures governing production and process controls. 21 CFR Part 11 governs how the electronic records and signatures documenting those changes must be maintained, not the change control requirement itself.

What are the regulatory requirements for change control in medical device manufacturing?

For medical device manufacturers, change control requirements are distributed across ISO 13485:2016. Clause 7.3.9 governs design and development changes, requiring that changes be identified, reviewed, verified or validated as appropriate, and approved before implementation. Clause 7.5.6 governs validation of processes for production and service provision, requiring that changes to validated processes be evaluated and revalidated where necessary. Under QMSR (21 CFR Part 820, effective February 2, 2026), these ISO 13485 requirements are incorporated by reference as the operative change control requirements for FDA-regulated device manufacturers. Changes affecting device design, labeling, or intended use may require a new 510(k) or PMA supplement under 21 CFR Part 814.

What is a validated state impact assessment in change control?

A validated state impact assessment is a structured evaluation of a proposed change against the parameters and acceptance criteria of an existing validated process, system, or method. Its purpose is to determine whether the proposed change falls within the established validated design space — in which case a documented change assessment with supporting data may be sufficient — or whether the change affects critical process parameters, critical quality attributes, or validated operating ranges in a way that requires the process to be revalidated before the change is implemented. In pharmaceutical and medical device GMP environments, implementing a process change without completing the required validated state impact assessment is a significant inspection finding.

How does change control software integrate with training management?

In a change control system without training integration, the completion of change approval and the creation of training assignments for affected employees are two separate, manually connected events. The change owner or training administrator must identify who needs training, create the assignments, and then track completion before allowing implementation — a process that frequently results in training being created after implementation rather than before. In eLeaP, training assignments are generated automatically when the change control record is approved, carrying the change control record number and the specific document version. Implementation sign-off is gated on confirmed training completion in the system — the connection between approval and implementation enforcement is automated, not manual.

What is a post-implementation review in change control?

A post-implementation review is a scheduled evaluation conducted after a change has been implemented to confirm that the change achieved its intended outcome without adverse effects on product quality, process performance, or regulatory compliance. ICH Q10 Section 3.2.3 requires post-implementation review as part of the Change Management System element of the Pharmaceutical Quality System. In practice, the review assesses process performance data from the post-implementation period — consecutive batch release data, in-process monitoring results, or revalidation protocol outcomes, depending on the change type — against the expected outcome defined in the change request. Any observations or concerns are documented, and unintended consequences trigger corrective action. A change control system that closes at implementation without a scheduled post-implementation review is not fully satisfying ICH Q10 requirements.

What change types require different workflows in regulated industries?

Regulated quality systems typically manage at least five distinct change types, each with different regulatory implications and workflow requirements: document changes (SOP revisions, specification updates, test method changes); process changes to validated manufacturing methods; equipment changes requiring requalification assessment; software changes to computerized systems requiring validation impact assessment under the applicable predicate rules (21 CFR Parts 211.68 and 211.100 for pharma, ISO 13485/QMSR for devices) with 21 CFR Part 11 governing the electronic records of those changes and EU Annex 11 for European operations; and organizational changes affecting quality responsibilities and approval authorities. A change control platform that applies a single workflow template to all five types cannot accommodate the different impact assessment domains, reviewer routing logic, and implementation gating requirements each type demands.

See eLeaP Change Control in a Scoped Demo

The demo covers a validated process change from initiation through impact assessment, validation impact determination, training gate, implementation sign-off, and post-implementation review — configured for your change types and regulatory framework.

Request a scoped evaluation at quality.eleapsoftware.com/get-free-demo/

Related resources: